Great West Life Assurance CO Lexicon Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 46,013 shares of LXRX stock, worth $17,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,013
Previous 46,013
-0.0%
Holding current value
$17,024
Previous $72,000
52.78%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LXRX
# of Institutions
132Shares Held
244MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$50.4 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$14.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$3.66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$3.66 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$3.33 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $69.8M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...